Falcon Point Capital’s Chembio diagnostics, Inc. CEMI Stock Holding History

Falcon Point Capital’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,345	Closed	-$88K	–	117
2019 Q4	$88K	Hold	19,345	–	–	0.11%	107
2019 Q3	$103K	Buy	+19,345	New	+$115K	0.06%	106

Other funds holding CEMI

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Falcon Point Capital's CEMI Position: Q1 2020 in Review

Falcon Point Capital sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2020, closing a stake of 19,345 shares — an estimated $88K sold.

Falcon Point Capital first reported a position in CEMI in Q3 2019 and held it in 2 quarters. The position peaked at $103K in Q3 2019. 42 funds tracked by Wall St. Rank hold CEMI as of Q1 2020.

Falcon Point Capital reported no remaining Chembio diagnostics, Inc. position as of Q1 2020 after selling out during the quarter.
Falcon Point Capital sold 19,345 Chembio diagnostics, Inc. shares in Q1 2020, an estimated $88K.
Falcon Point Capital first reported a position in Chembio diagnostics, Inc. in Q3 2019 and held it in 2 quarters.
Falcon Point Capital's Chembio diagnostics, Inc. position peaked at $103K in Q3 2019.
42 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2020.

Based on Falcon Point Capital's 13F filing for Q1 2020, filed 22 Apr 2020.